FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2022 Company IndustryThis FIRST AMENDED EMPLOYMENT AGREEMENT dated March 29, 2022, and effective as of January 31, 2022, (this “Agreement”) between Virpax Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Jeffrey Gudin, MD (the “Executive”).
Certain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed. AMENDED & RESTATED COLLABORATION AND LICENSE AGREEMENT BETWEEN NANOMERICS Ltd AND VIRPAX PHARMACEUTICALS, INC.Collaboration and License Agreement • March 31st, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2022 Company IndustryThis Amended & Restated Collaboration and License Agreement (this “Agreement”) is made effective as of the 9th day of March 2022 (the “New Effective Date”), by and between
FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2022 Company IndustryThis FIRST AMENDED EMPLOYMENT AGREEMENT dated March 29, 2022, and effective as of January 31, 2022, (this “Agreement”) between Virpax Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Christopher Chipman (the “Executive”).
FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2022 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2022 Company IndustryThis FIRST AMENDED EMPLOYMENT AGREEMENT dated March 29, 2022, and effective as of January 31, 2022 (this “Agreement”) between Virpax Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Anthony P. Mack (the “Executive”).